No abstract available
Keywords:
Nilotinib; chronic myelogenous leukemia; scurvy; tyrosine kinase inhibitor.
MeSH terms
-
Aged
-
Antineoplastic Agents / adverse effects*
-
Humans
-
Keratosis / etiology*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Male
-
Pyrimidines / adverse effects*
-
Scurvy / chemically induced*
-
Scurvy / pathology
Substances
-
Antineoplastic Agents
-
Pyrimidines
-
nilotinib